رادار التجارب AI | ||
|---|---|---|
حالة التجربة السريرية NCT05058508 لـ سرطان الأطفال هي قيد التجنيد. اطلعوا على جميع التفاصيل في عرض البطاقة الخاص برادار التجارب السريرية وأدوات اكتشاف الذكاء الاصطناعي. أو يمكنكم طرح أي سؤال هنا. | ||
تجربة واحدة تطابق معايير الفلتر
عرض البطاقة
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
تفاصيل التجربة السريرية متاحة بشكل أساسي باللغة الإنجليزية. ومع ذلك، يمكن لـ 'رادار التجارب AI' أن يساعدك؛ ما عليك سوى النقر على 'وصف الدراسة' لعرض ومناقشة معلومات التجربة باللغة التي اخترتها.
التجربة السريرية NCT05058508 هي دراسة تدخُّلية لـسرطان الأطفال وهي قيد التجنيد. بدأت في ١ رمضان ١٤٤٥ هـ مع خطة لتجنيد ٦٠ مشاركًا. يقودها جامعة ويك فورست، ومن المتوقع اكتمالها بحلول ٢ جمادى الآخرة ١٤٤٩ هـ. تم تحديث البيانات الأخيرة من ClinicalTrials.gov في ٢١ محرم ١٤٤٧ هـ.
الملخص
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
وصف مفصل
This is a randomized, controlled trial to investigate if a structured exercise regimen will have benefit relative to the control arm by increasing and /or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test and BOT-2 Brief or PDMS-2.
العنوان الرسمي
LCI-PED-NOS-EXER-001: Just Move. A Randomized Controlled Trial Investigating Exercise in Pediatric Oncology Patients
الحالات الطبية
سرطان الأطفالمعرّفات دراسة أخرى
- IRB00082746
- LCI-PED-NOS-EXER-001 (معرف آخر) (Atrium)
NCT معرّف
تاريخ البدء (فعلي)
2024-03-11
آخر تحديث مُنشور
2025-07-16
تاريخ الاكتمال (المقدر)
2027-11
عدد المشاركين المخطط لهم
٦٠
نوع الدراسة
تدخُّلية
المرحلة
غ/م
الحالة
قيد التجنيد
الكلمات الرئيسية
Exercise
Pediatric Oncology
Pediatric Oncology
الغرض الأساسي
الرعاية الداعمة
طريقة توزيع المشاركين
عشوائي
نموذج التدخل
التصميم المتوازي
التعمية
لا شيء (مفتوحة)
مجموعات/التدخلات
| مجموعة المشاركين/مجموعة | تَدَخُّل/علاج |
|---|---|
تجريبيةEXER "Just Move" exercises | "Just Move" Exercise Subjects complete "Just Move" Exercises Five Times Per Week |
تجريبيةSOC EXER Standard of Care Exercise | Standard of Care Exercise Subjects exercise/move as tolerated |
النتيجة الرئيسية
النتيجة الثانوية
| مقياس النتيجة | وصف القياس | الإطار الزمني |
|---|---|---|
Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment | Investigate if 20 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test | 18 month period |
Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment | Investigate if 20 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by BOT-2 Brief (in subjects ≥ 4 years of age) or PDMS-2 (in subjects \< 4 years of age). | 18 month period |
| مقياس النتيجة | وصف القياس | الإطار الزمني |
|---|---|---|
Adverse Event Rate | Occurrence of Adverse Events of Special Interest (thromboembolic event, skin ulceration, significant nausea/vomiting, and constipation) will be measured as binary variables. | up to 18 months |
Quality of Life measured by the PedsQL Cancer Module | Investigate if a structured exercise regimen relative to the control arm will result in Increasing and /or maintaining quality of life as measured by the PedsQL Cancer Module. Peds QL scores will be calculated as a composite quantitative analogue variable ranging from zero (best score) to 100 (worst score). | up to 18 months |
Subject adherence to exercise regimen | Subject adherence to exercise regimen will be determined by patient-reported tracker listing activity performed and duration of time of activity. Data collected will be normalized quantitatively based on intended activity. | up to 18 months |
Adverse Events Related to Exercise Program | To summarize adverse event rates deemed to be related to the protocol directed exercise program. Adverse events of special interest (Grade 2 or greater Bone fracture, Fall, and Muscle aches/Myalgia) will be captured for each subject and time point randomized to the intervention arm. | up to 18 months |
معايير الأهلية
الأعمار المؤهلة للدراسة
طفل, بالغ
العمر الأدنى للدراسة
2 Years
الجنس المؤهل
الكل
- Ages 2-25 at time of consent
- Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles
- Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
- As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
- Subject has newly diagnosed cancer per Investigator and is planning to undergo chemotherapy, immunotherapy, or other systemically delivered for treatment of malignancy. Subjects are allowed to be enrolled up to 5 days after initiating cancer treatment.
- Receiving oncologic care at Levine Children's Cancer and Blood Disorders Clinic.
- Subject is anticipated to receive at least 3 full cycles90 days of chemotherapy or other systemic cancer treatment.
- Not participating in another clinical trial that precludes participating in additional nondrug clinical trials.
- Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
- Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator.
- Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
- Primary CNS Tumor
- Osteosarcoma
جهة اتصال مركزية للدراسة
جهة اتصال: Meg Lattanze, (980) 442-4239, [email protected]
1 مواقع الدراسة في 1 بلدان
North Carolina
Levine Children's Hospital, Charlotte, North Carolina, 28203, United States
Meg Lattanze, جهة اتصال, 980-442-4239, [email protected]
Jennifer Pope, MD, المحقق الرئيسي
قيد التجنيد